{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:45:46Z","timestamp":1793051146267,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474187"],"award-info":[{"award-number":["82474187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973693"],"award-info":[{"award-number":["81973693"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bbrc.2025.151709","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T15:52:19Z","timestamp":1743090739000},"page":"151709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Aptamer inhibits P-glycoprotein efflux function via the Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1016","volume":"760","author":[{"given":"Yujuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6697-1892","authenticated-orcid":false,"given":"Qiuxia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151709_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.013","article-title":"Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy","volume":"149","author":"Silva","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151709_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1248\/bpb.b17-00725","article-title":"Advances in studies of P-glycoprotein and its expression regulators","volume":"41","author":"Yano","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrc.2025.151709_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/bdd.2331","article-title":"The role of the efflux transporter, P-glycoprotein, at the blood-brain barrier in drug discovery, Biopharm","volume":"44","author":"Cox","year":"2023","journal-title":"Drug Dispos"},{"key":"10.1016\/j.bbrc.2025.151709_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4976","article-title":"Metabolomics analysis of multidrug resistance in colorectal cancer cell and multidrug resistance reversal effect of verapamil","volume":"35","author":"Wang","year":"2021","journal-title":"Biomed. Chromatogr. BMC"},{"key":"10.1016\/j.bbrc.2025.151709_bib5","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.2174\/1381612825666191112142943","article-title":"Wnt-\u03b2-catenin signaling pathway, the achilles' heels of cancer multidrug resistance","volume":"25","author":"Ghandadi","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbrc.2025.151709_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00432-022-04387-2","article-title":"Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents","volume":"149","author":"Shah","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.151709_bib7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.21873\/anticanres.16255","article-title":"Low-dose pimecrolimus, an FDA-approved calcineurin inhibitor, sensitizes drug-resistant cancer cells via strong P-gp inhibition","volume":"43","author":"Park","year":"2023","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2025.151709_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122274","article-title":"Capture-SELEX for aptamer selection: a short review","volume":"229","author":"Lyu","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.bbrc.2025.151709_bib9","first-page":"1236","article-title":"Research on selecting of P-gp aptamers and its application","volume":"41","author":"Li","year":"2021","journal-title":"Trans. Beijing Inst. Technol."},{"key":"10.1016\/j.bbrc.2025.151709_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.colsurfb.2009.03.005","article-title":"Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion","volume":"71","author":"Gao","year":"2009","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbrc.2025.151709_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/bdd.2367","article-title":"Association between \u03b1-defensin 5 and the expression and function of P-glycoprotein in differentiated intestinal Caco-2 cells","volume":"44","author":"Yasuda","year":"2023","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.bbrc.2025.151709_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11095-018-2377-6","article-title":"Ionophore and biometal modulation of P-glycoprotein expression and function in human brain microvascular endothelial cells","volume":"35","author":"McInerney","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbrc.2025.151709_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijpharm.2014.11.035","article-title":"In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities","volume":"478","author":"Stappaerts","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2025.151709_bib14","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1016\/j.xphs.2016.09.002","article-title":"Effects of 2 polyoxyethylene alkyl ethers on the function of intestinal P-glycoprotein and their inhibitory mechanisms","volume":"105","author":"Zhao","year":"2016","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.bbrc.2025.151709_bib15","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.bcp.2008.01.004","article-title":"Insulin therapy restores impaired function and expression of P-glycoprotein in blood\u2013brain barrier of experimental diabetes","volume":"75","author":"Liu","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151709_bib16","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1021\/mp300334r","article-title":"P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt\/\u03b2-catenin and endothelin-1 signaling","volume":"10","author":"Harati","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbrc.2025.151709_bib17","first-page":"138","article-title":"In situ intestinal perfusion of irinotecan: application to P-gp mediated drug interaction and introduction of an improved HPLC assay","volume":"14","author":"Rabba","year":"2011","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.bbrc.2025.151709_bib18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3109\/00498254.2014.920551","article-title":"Characterization of gastrointestinal absorption of digoxin involving influx and efflux transporter in rats: application of mdr1a knockout (\u2212\/\u2212) rats into absorption study of multiple transporter substrate","volume":"44","author":"Suzuki","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bbrc.2025.151709_bib19","doi-asserted-by":"crossref","DOI":"10.34133\/2021\/9835728","article-title":"Investigation on P-glycoprotein function and its interacting proteins under simulated microgravity","volume":"2021","author":"Li","year":"2021","journal-title":"Space Sci. Technol."},{"key":"10.1016\/j.bbrc.2025.151709_bib20","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.3390\/ijms24065438","article-title":"Simulated microgravity alters P-glycoprotein efflux function and expression via the Wnt\/\u03b2-catenin signaling pathway in rat intestine and brain","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151709_bib21","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.3390\/molecules23123055","article-title":"Taxifolin resensitizes multidrug resistance cancer cells via uncompetitive inhibition of P-glycoprotein function","volume":"23","author":"Chen","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2025.151709_bib22","doi-asserted-by":"crossref","first-page":"9444","DOI":"10.1016\/j.biomaterials.2011.08.041","article-title":"Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance","volume":"32","author":"Wang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2025.151709_bib23","first-page":"30","article-title":"Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: a potent approach to treat amyotrophic lateral sclerosis","volume":"120","author":"Yang","year":"2018","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.bbrc.2025.151709_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.21037\/jgo-22-167","article-title":"Clinical significance and correlation of miR-200c and P-gp expression in gastric cancer and the effects on multidrug resistance","volume":"13","author":"Wang","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.bbrc.2025.151709_bib25","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.14336\/AD.2022.0225","article-title":"P-glycoprotein aggravates blood brain barrier dysfunction in experimental ischemic stroke by inhibiting endothelial autophagy","volume":"13","author":"Huang","year":"2022","journal-title":"Aging Dis"},{"key":"10.1016\/j.bbrc.2025.151709_bib26","article-title":"TRPC5 mediates TMZ resistance in TMZ-resistant glioblastoma cells via NFATc3-P-gp pathway","volume":"14","author":"Yan","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbrc.2025.151709_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bmc.2007.09.039","article-title":"Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives","volume":"16","author":"Colabufo","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151709_bib28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/life12060897","article-title":"Multidrug resistance of cancer cells and the vital role of P-glycoprotein","volume":"12","author":"Karthika","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.bbrc.2025.151709_bib29","first-page":"161","article-title":"Aptamer-modified nanoparticles in medical applications","volume":"174","author":"Eilers","year":"2020","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"10.1016\/j.bbrc.2025.151709_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100681","article-title":"Medicinal chemistry strategies to discover P-glycoprotein inhibitors: an update","volume":"49","author":"Dong","year":"2020","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2025.151709_bib31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/17425247.2018.1517749","article-title":"Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery","volume":"15","author":"Kou","year":"2018","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.bbrc.2025.151709_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejmech.2017.06.047","article-title":"Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer","volume":"138","author":"Joshi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151709_bib33","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1021\/mp300334r","article-title":"P-glycoprotein, breast cancer resistance protein, organic anion transporter 3, and transporting peptide 1a4 during blood\u2013brain barrier maturation: involvement of Wnt\/\u03b2-Catenin and Endothelin-1 signaling","volume":"10","author":"Harati","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbrc.2025.151709_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/fcp.12219","article-title":"Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cells","volume":"30","author":"Marsousi","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151709_bib35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clpt.2004.09.001","article-title":"P-glycoprotein and surfactants: effect on intestinal talinolol absorption","volume":"77","author":"Bogman","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151709_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2025.151709_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pharmthera.2018.11.008","article-title":"Activating Wnt\/\u03b2-catenin signaling pathway for disease therapy: challenges and opportunities","volume":"196","author":"Huang","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151709_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.34133\/research.0289","article-title":"Dissection of FOXO1-induced LYPLAL1-DT impeding triple-negative breast cancer progression via mediating hnRNPK\/\u03b2-Catenin complex","volume":"6","author":"Tang","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.bbrc.2025.151709_bib39","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41419-023-06115-1","article-title":"AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer","volume":"14","author":"Tian","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2025.151709_bib40","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1021\/mp300334r","article-title":"P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt\/\u03b2-catenin and endothelin-1 signaling","volume":"10","author":"Harati","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbrc.2025.151709_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","article-title":"Wnt signaling in colorectal cancer: pathogenic role and therapeutic target","volume":"21","author":"Zhao","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2025.151709_bib42","doi-asserted-by":"crossref","first-page":"115803","DOI":"10.18632\/oncotarget.23253","article-title":"Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt\/\u03b2-catenin signaling","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2025.151709_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pharmthera.2018.11.008","article-title":"Activating Wnt\/\u03b2-catenin signaling pathway for disease therapy: challenges and opportunities","volume":"196","author":"Huang","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2025.151709_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuint.2014.05.004","article-title":"Dysfunctional Wnt\/\u03b2-catenin signaling contributes to blood\u2013brain barrier breakdown in Alzheimer's disease","volume":"75","author":"Liu","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbrc.2025.151709_bib45","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/membranes11120992","article-title":"Cytochrome P450 and P-gp mediated herb-drug interactions and molecular docking studies of garcinol","volume":"11","author":"Bolla","year":"2021","journal-title":"Membranes"},{"key":"10.1016\/j.bbrc.2025.151709_bib46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbrc.2021.03.076","article-title":"A human epidermal growth factor receptor 3\/heregulin interaction inhibitor aptamer discovered using SELEX","volume":"553","author":"Yokoyama","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.151709_bib47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.omtn.2017.12.015","article-title":"Targeting EGFR\/HER2\/HER3 with a Three-in-One aptamer-siRNA chimera confers superior activity against HER2+ breast cancer","volume":"10","author":"Yu","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2025.151709_bib48","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3390\/ph6121507","article-title":"Aptamer-based therapeutics: new approaches to combat human viral diseases","volume":"6","author":"Shum","year":"2013","journal-title":"Pharmaceuticals"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25004231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25004231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:20:49Z","timestamp":1744096849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25004231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":48,"alternative-id":["S0006291X25004231"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151709","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aptamer inhibits P-glycoprotein efflux function via the Wnt\/\u03b2-catenin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151709"}}